phosphorylethanolamine has been researched along with Epilepsy Progressive Myoclonic 2 in 1 studies
phosphorylethanolamine: RN given refers to parent cpd; structure
O-phosphoethanolamine : The ethanolamine mono-ester of phosphoric acid, and a metabolite of phospholipid metabolism. This phosphomonoester shows strong structural similarity to the inhibitory neurotransmitter GABA, and is decreased in post-mortem Alzheimer's disease brain.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alisauskaite, N | 1 |
| Beckmann, K | 1 |
| Dennler, M | 1 |
| Zölch, N | 1 |
1 other study available for phosphorylethanolamine and Epilepsy Progressive Myoclonic 2
| Article | Year |
|---|---|
Brain proton magnetic resonance spectroscopy findings in a Beagle dog with genetically confirmed Lafora disease.
Topics: Animals; Aspartic Acid; Brain; Choline; Dog Diseases; Dogs; Ethanolamines; Female; Glutamic Acid; Gl | 2020 |